Eliem Therapeutics's total assets for Q3 2023 were $112.73M, a decrease of -3.04% from the previous quarter. ELYM total liabilities were $2.99M for the fiscal quarter, a -20.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.